By creating functional, lab-grown organs tailored to individual patients, bioprinting not only reduces reliance on donors but also mitigates the risks of rejection and a lifetime of immunosuppressive medications. Bioprinted organs can also mimic the intricate structures and functions of human tissues for testing personalised therapies, particularly for treating complex conditions.